**Author details**

Dragoș Cătălin Jianu1,2\*, Silviana Nina Jianu3 , Georgiana Munteanu<sup>2</sup> , Traian Flavius Dan<sup>2</sup> and Claudia Birsan<sup>2</sup>

1 Department of Neurology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania

2 Department of Neurology, Clinical Emergency County Hospital, Timisoara, Romania

3 Department of Ophthalmology, Military Emergency Hospital, Timisoara, Romania

\*Address all correspondence to: dcjianu@yahoo.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**99**

*Diagnosis of Symptomatic Intracranial Atherosclerotic Disease*

[9] Bang OY, Saver JL, Liebeskind DS, Pineda S, Yun SW, Ovbiagele B. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group. Journal of the Neurological Sciences.

[10] Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya

disease gene. Journal of Human

[11] Hachinski V. Stroke in Korean.

[12] Prabhakaran S, Romano JG. Current diagnosis and management

atherosclerotic disease. Current Opinion in Neurology. 2012;**25**(1):18-26. DOI: 10.1097/WCO.0b013e32834ec16b

of symptomatic intracranial

[13] Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New England Journal of Medicine. 2005;**352**:1305-1316

[14] Lopez-Cancio E, Dorado L, Millan L, Alzamora M, Reverte S, Sunol A, et al. Final results of the Barcelona-Asymptomatic Intracranial

Atherosclerosis (ASIA) study: Prevalence and risk factors. Stroke.

[16] Bang OY. Intracranial

[15] Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology. 2007;**68**:2035-2038

atherosclerosis: Current understanding and perspectives. Journal of Stroke.

2011;**42**:e87-e88

2014;**16**(1):27-35

Genetics. 2011;**56**:34-40

Stroke. 2008;**39**:1067

(Review)

2009;**284**:40-45

*DOI: http://dx.doi.org/10.5772/intechopen.90250*

[1] Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: A review.

[3] Arenillas JF. Intracranial atherosclerosis: Current concepts. Stroke. 2011;**42**:S20-S23. DOI: 10.1161/

STROKEAHA.110.597278

2006;**1**:158-159

Stroke. 1995;**26**:14-20

2005;**65**:296-298

10.1159/000448309

[4] Wong LK. Global burden of intracranial atherosclerosis. International Journal of Stroke.

[5] Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

[6] Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology.

[7] Kim JS, Caplan LR, Wong KS. Intracranial atherosclerosis: Pathophysiology, diagnosis and treatment. Frontiers of Neurology and Neuroscience. 2016;**40**:34-43. DOI:

[8] Mak W, Cheng TS, Chan KH, Cheung RT, Ho SL. A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease: Ancestral european settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries. Medical Hypotheses. 2005;**65**:637-648

[2] Gorelick PB, Wong LK, Bae H, Pandey D. Large artery intracranial occlusive disease, a large worldwide burden but a relatively neglected frontier. Stroke. 2008;**39**:2396-2399

Stroke. 1986;**17**:648-655

**References**
